CDKN2A mAb (BCWJC-1908) NCI-H929 [H929] B Cell Engineering Cassette (CAT#: BGS-0124-CR2213)

This product is a NCI-H929 [H929] B cell engineering tool based on the Gold nanoparticles (Anti-EGFR mAb/Epidermal GrowthFactor Receptor) delivery system and CRISPR-based (CCR5-huIgH296-Cas9-Brefeldin A ) genome editor.

Datasheet

Specifications

Host Cell NCI-H929 [H929]
Target CDKN2A
Insert Clone BCWJC-1908
Safe Harbor Sites (SHS) CCR5
gRNA huIgH296
Nuclease Cas9
Enhancer Brefeldin A
Targeting Strategy pH responsive, mucoadhesiveness
Insertion sites Mouse genome E-1
Vehicles Gold nanoparticles
Ligand/Receptor EGFR mAb/Epidermal Growth
Factor Receptor
Active Agents 5-Fluorouracil (5-FU)
Particle Size 20-3500
Charge (mv) ≤50
Total Atom Count ~60,000,000
Surface Atoms (%) ~0.8
Specific Surface Area (m2/g) ~2.5
Vector Type AAV
Vector Name BCpCDH1
Targeting Diseases Ovarian cancer; Breast cancer; Pancreatic cancer
COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number
! For Research Use Only | Not For Clinical Use

Related products